This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Depression, Postpartum
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The proposed study aims to establish the feasibility of light therapy for postpartum depression delivered via Re-Timer, demonstrate its preliminary efficacy, and illuminate relationships between circadian shifts and mood changes using a novel, home-based circadian biomarker assessment paradigm (salivary dim light melatonin onset; DLMO).

Provided treatments

  • Device: Light therapy
Tris trial is registered with FDA with number: NCT02769858. The sponsor of the trial is University of Michigan and it is looking for 10 volunteers for the current phase.
Official trial title:
The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression